Common questions, plain answers.

The compounds you read about on this site are sold by their suppliers under the U.S. research-chemical exemption: labelled “for research use only” / “not for human consumption”, and shipped to buyers who represent themselves as researchers. That label is how every retailer in this space is legally allowed to ship the product door-to-door in the first place.

What it means for you, on the ground, is that the legality of possessing and using one of these compounds sits with the buyer and with whatever the relevant authority — federal, state, local, sporting federation — says about that specific compound in that specific context. We are not the right place to ask whether a particular peptide is legal for you to buy where you live; the supplier you buy from, and a lawyer who knows your jurisdiction, are.

“Research use only” is also the answer to the safety question. The published human evidence for most of these compounds is thin, mixed, or several decades old; newer analogues frequently have no human trials at all. The short version is that working with research peptides is closer to handling a laboratory reagent than to taking an over-the- counter medicine, and the safety profile reflects that.

That is the editorial line we keep on each brief, and it is the one you should plan around. Read what the published literature says, read the supplier’s own handling and storage guidance, and decide — with a licensed clinician who has the full picture of your health — whether the question is even one you should be asking.

Almost every compound on this site splits, by route, into two camps, and they are not interchangeable. An oral milligram and an injectable milligram of the same labelled molecule are not the same thing in your bloodstream.

• Oral.Swallowed, absorbed through the gastrointestinal tract. Most of the dose never reaches circulation; what does is processed by the liver first (the “first-pass” effect). Doses run higher to compensate. Convenience is the upside; bioavailability is the trade-off.
• Injectable. Delivered subcutaneously (under the skin) or intramuscularly (into the muscle). Bypasses the GI tract and the first-pass effect — more of the dose reaches circulation, often at a smaller amount. Sterile technique, storage, and a legitimate supplier are the trade-offs.

The supplier named on any given brief sells one route. Their dosing guidance, not ours, is the number to read against.

Every product block names one specific supplier — and only that supplier — so the storefront behind the listing is never anonymous. Each brief publishes the source it relies on: published literature for the compound, the supplier’s own published material for product-level claims, and the community-standard references that working researchers already cite. Where a supplier’s claims outrun the literature we say so on the page.

This is an editorial storefront, not a clinic and not a pharmacy, so the vetting is editorial: does the supplier publish a real product spec, a real third-party test, and real contact information that a buyer can act on. We do not dispense, dose, or substitute for a licensed clinician — and the line on a compound is the same whether the link pays us today or not.

Because we are not a medical service, and because none of the compounds on this site are approved by the regulator for the way most readers actually use them. Anything we wrote in the imperative — take this, that dose, for that outcome — would be a medical claim attached to a research-labelled product, and that is not a line a careful storefront crosses.

So the briefs describe what a compound is, what it is researched for, and who is selling it. They do not diagnose, prescribe, treat, or recommend. If a brief here disagrees with a licensed clinician who has the full picture of your health, the clinician wins — always.